1. Home
  2. BGSF vs DRIO Comparison

BGSF vs DRIO Comparison

Compare BGSF & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGSF Inc.

BGSF

BGSF Inc.

HOLD

Current Price

$5.53

Market Cap

55.0M

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$6.56

Market Cap

60.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGSF
DRIO
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.0M
60.6M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
BGSF
DRIO
Price
$5.53
$6.56
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
12.6K
6.0K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
36.04%
N/A
EPS Growth
N/A
1559.02
EPS
N/A
1.25
Revenue
$93,310,000.00
$7,394,000.00
Revenue This Year
$4.67
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
N/A
$5.54
Revenue Growth
N/A
43.02
52 Week Low
$3.26
$0.38
52 Week High
$8.20
$17.74

Technical Indicators

Market Signals
Indicator
BGSF
DRIO
Relative Strength Index (RSI) 60.67 27.22
Support Level $5.49 $6.16
Resistance Level $5.79 $9.46
Average True Range (ATR) 0.18 0.41
MACD 0.06 -0.09
Stochastic Oscillator 90.65 18.48

Price Performance

Historical Comparison
BGSF
DRIO

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. The company operates in one segment of Property Management, which includes centralized support services through executive, marketing, human resources, information technology, accounting, treasury, and billing operations.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: